Trailhead Capital | Activity

Essay

Trailhead published a detailed portfolio proof points piece on Substack showing how six portfolio companies (Local Line, Avalo, Funga, Edacious, HowGood, Ascribe Bio) are securing commercial contracts with major brands like Chipotle, Netflix, Nestlé, Coca-Cola, and Syngenta.

Trailhead Capital

Trailhead CapitalTrailhead Capital

trailheadcapital.substack.comSEP 29, 2026

SEP 29, 2026

Milestone

Ascribe Bio (Trailhead portfolio company) received first regulatory approval in Brazil for Phytalix biofungicide, enabling 2026/27 commercial launch with a new biological mode of action.

Ascribe Bio

Ascribe Bio Trailhead Capital

trailheadcap.comSEP 29, 2026

SEP 29, 2026

Milestone

Trailhead published a portfolio proof points piece showing how Fund I portfolio companies are reshaping the U.S. Food & Ag system with commercial contracts validating the regenerative agriculture thesis.

Trailhead Capital

Trailhead CapitalTrailhead Capital

trailheadcap.comSEP 29, 2026

SEP 29, 2026

Investment

Trailhead Capital participated in SWARM Engineering's $10M Series A round led by S2G Investments and AgRogue Growth Partners. SWARM provides AI-powered decision intelligence for agrifood and manufacturing supply chains.

Swarm Engineering

Swarm Engineering Trailhead Capital

tmcnet.comJUN 10, 2026

JUN 10, 2026

Essay

Trailhead published an essay on the science behind nutrient density and why not all food is created equal, reinforcing their food-as-medicine thesis.

Trailhead Capital

Trailhead CapitalTrailhead Capital

trailheadcap.comMAY 11, 2026

MAY 11, 2026

Exit

Portfolio company Eion was acquired by Terradot, advancing enhanced rock weathering for carbon removal.

Eion

EionTrailhead Capital

tracxn.comFEB 2026 techcrunch.com businesswire.com agfundernews.com tracxn.com

FEB 2026

Investment

Invested in HerdDogg, providing wireless animal health and welfare tracking for livestock producers.

HerdDogg

HerdDogg Trailhead Capital

pitchbook.comDEC 2025

DEC 2025

Investment

Invested in Ascribe Bioscience Series A, developing bio-based crop protection from soil microbiome.

Ascribe Bio

Ascribe Bio Trailhead Capital

forbes.comOCT 2025

OCT 2025

New Fund

Trailhead Capital is targeting $75M-$100M for its successor Fund II, with plans to hold first close later in 2025. The fund will feature largely the same team and investment thesis as Fund I.

Trailhead Capital

Trailhead CapitalTrailhead Capital

globalaginvesting.comAUG 20, 2025

AUG 20, 2025

Investment

Trailhead Capital invested in TerraBlaster's oversubscribed $4M pre-seed round alongside Khosla Ventures and OCP Group. TerraBlaster uses NASA-developed LIBS laser technology for real-time soil diagnostics.

TerraBlaster

TerraBlaster Trailhead Capital

globalaginvesting.comAUG 20, 2025

AUG 20, 2025

Essay

Published an essay on finding investment value in the agricultural economy beyond farmgate operations.

An Informal Guide to Finding Value in the Ag Economy

Trailhead Capital

trailheadcap.comJUL 31, 2025

JUL 31, 2025

Exit

Portfolio company Trace Genomics was acquired, providing soil microbiome sequencing for agricultural optimization.

Trace Genomics

Trace Genomics Trailhead Capital

crunchbase.comJUL 2025

JUL 2025

Essay

Published an essay on the market infrastructure needed to support regenerative farming practices.

How to Build a Market for Regenerative Agriculture

Trailhead Capital

trailheadcap.comJUN 26, 2025

JUN 26, 2025

Trailhead Capital Activity

Trailhead published a detailed portfolio proof points piece on Substack showing how six portfolio companies (Local Line, Avalo, Funga, Edacious, HowGood, Ascribe Bio) are securing commercial contracts with major brands like Chipotle, Netflix, Nestlé, Coca-Cola, and Syngenta.

Trailhead Capital Co-Founder & Managing Partner Pete Oberle joined the Board of the Regenerative Organic Alliance (ROC), the certification standard for regenerative claims.

Ascribe Bio (Trailhead portfolio company) received first regulatory approval in Brazil for Phytalix biofungicide, enabling 2026/27 commercial launch with a new biological mode of action.

Trailhead published a portfolio proof points piece showing how Fund I portfolio companies are reshaping the U.S. Food & Ag system with commercial contracts validating the regenerative agriculture thesis.

Trailhead Capital participated in SWARM Engineering's $10M Series A round led by S2G Investments and AgRogue Growth Partners. SWARM provides AI-powered decision intelligence for agrifood and manufacturing supply chains.

Trailhead published an essay on the science behind nutrient density and why not all food is created equal, reinforcing their food-as-medicine thesis.

Portfolio company Eion was acquired by Terradot, advancing enhanced rock weathering for carbon removal.

Invested in HerdDogg, providing wireless animal health and welfare tracking for livestock producers.

Invested in Ascribe Bioscience Series A, developing bio-based crop protection from soil microbiome.

Trailhead Capital is targeting $75M-$100M for its successor Fund II, with plans to hold first close later in 2025. The fund will feature largely the same team and investment thesis as Fund I.

Trailhead Capital invested in TerraBlaster's oversubscribed $4M pre-seed round alongside Khosla Ventures and OCP Group. TerraBlaster uses NASA-developed LIBS laser technology for real-time soil diagnostics.

Published an essay on finding investment value in the agricultural economy beyond farmgate operations.

Portfolio company Trace Genomics was acquired, providing soil microbiome sequencing for agricultural optimization.

Published an essay on the market infrastructure needed to support regenerative farming practices.